Publication
Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort
Journal Paper/Review - Jan 1, 2006
Simon Dagmar, Gilgen Bobalj Nicole, Schmid-Grendelmeier Peter, Braathen Lasse R, Schöni Martin H, Anliker Mark, Laffitte Emmanuel, Weber M Monika, Wiesner Alice, Wüthrich Brunello, Lübbe Jann, Schneider Dirk
Units
PubMed
Doi
Citation
Simon D, Gilgen Bobalj N, Schmid-Grendelmeier P, Braathen L, Schöni M, Anliker M, Laffitte E, Weber M, Wiesner A, Wüthrich B, Lübbe J, Schneider D. Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort. Dermatology (Basel) 2006; 213:313-8.
Type
Journal Paper/Review (English)
Journal
Dermatology (Basel) 2006; 213
Publication Date
Jan 1, 2006
Issn Print
1018-8665
Pages
313-8
Brief description/objective
Controlled studies established the efficacy and good tolerability of pimecrolimus cream 1% for the treatment of atopic dermatitis but they may not reflect real-life use.